Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Sep;31(9):1442–1443. doi: 10.1128/aac.31.9.1442

Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up.

W Brumfitt 1, J M Hamilton-Miller 1, G W Smith 1
PMCID: PMC174961  PMID: 3674851

Abstract

Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily). The poor performance of cefuroxime axetil is explained by variable bioavailability.

Full text

PDF
1442

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Wood M. J., Farrell I. D., Fox C., Ball A. P. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection. J Antimicrob Chemother. 1985 Sep;16(3):359–366. doi: 10.1093/jac/16.3.359. [DOI] [PubMed] [Google Scholar]
  2. Brumfitt W., Hamilton-Miller J. M. Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin. Br J Clin Pract. 1985 Sep;39(9):346–351. [PubMed] [Google Scholar]
  3. Brumfitt W., Hamilton-Miller J. M., Ludlam H., Damjanovic V., Gargan R. Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections. Infection. 1982 Sep-Oct;10(5):280–284. doi: 10.1007/BF01640874. [DOI] [PubMed] [Google Scholar]
  4. Brumfitt W., Smith G. W., Hamilton-Miller J. M., Bax R. Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection. J Antimicrob Chemother. 1985 Dec;16(6):781–788. doi: 10.1093/jac/16.6.781. [DOI] [PubMed] [Google Scholar]
  5. Cooper T. J., Ladusans E., Williams P. E., Polychronopoulos V., Gaya H., Rudd R. M. A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. J Antimicrob Chemother. 1985 Sep;16(3):373–378. doi: 10.1093/jac/16.3.373. [DOI] [PubMed] [Google Scholar]
  6. Gargan R., Brumfitt W., Hamilton-Miller J. M. A concise biotyping system for differentiating strains of Escherichia coli. J Clin Pathol. 1982 Dec;35(12):1366–1369. doi: 10.1136/jcp.35.12.1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harding S. M., Williams P. E., Ayrton J. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers. Antimicrob Agents Chemother. 1984 Jan;25(1):78–82. doi: 10.1128/aac.25.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. O'Callaghan C. H., Sykes R. B., Ryan D. M., Foord R. D., Muggleton P. W. Cefuroxime - a new cephalosporin antibiotic. J Antibiot (Tokyo) 1976 Jan;29(1):29–37. doi: 10.7164/antibiotics.29.29. [DOI] [PubMed] [Google Scholar]
  9. Reichman R. C., Nolte F. S., Wolinsky S. M., Greisberger C. A., Trupei M. A., Nitzkin J. Single-dose cefuroxime axetil in the treatment of uncomplicated gonorrhea: a controlled trial. Sex Transm Dis. 1985 Oct-Dec;12(4):184–187. doi: 10.1097/00007435-198510000-00003. [DOI] [PubMed] [Google Scholar]
  10. Sommers D. K., Van Wyk M., Williams P. E., Harding S. M. Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing. Antimicrob Agents Chemother. 1984 Mar;25(3):344–347. doi: 10.1128/aac.25.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Williams P. E., Harding S. M. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food. J Antimicrob Chemother. 1984 Feb;13(2):191–196. doi: 10.1093/jac/13.2.191. [DOI] [PubMed] [Google Scholar]
  12. Wise R., Bennett S. A., Dent J. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid. J Antimicrob Chemother. 1984 Jun;13(6):603–610. doi: 10.1093/jac/13.6.603. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES